Skip to main content
Top
Published in: Journal of Neuro-Oncology 3/2011

01-07-2011 | Clinical Study – Patient Study

Clear cell meningioma with frequent chordoid features and aggressive behavior: a clinicopathologic study of ten cases at a single institution

Authors: Han-Ku Chen, You-Ting Wu, Yu-Jun Lin, Jui-Wei Lin

Published in: Journal of Neuro-Oncology | Issue 3/2011

Login to get access

Abstract

Clear cell meningioma is an uncommon variant of meningiomas that often occurs in young patients, shows a proclivity for spinal intradural extramedullary and cerebellopontine angle, and follows an aggressive clinical course. We render clinicopathologic features of ten cases of this rare tumor to further elucidate its behavior. Fifteen specimens of clear cell meningioma belonging to ten patients were obtained at a single institution from 2001 to 2009. Correlations of histologic parameters, immunohistochemical study, and clinical features were assessed. This series included eight men and two women with a mean age of 62.1 years at the first surgery. The mean post-operative follow-up period was 3.9 years. Four patients (40%) had single or multiple local tumor recurrences. The mean time to recurrence was 2.3 years. Seven tumors (46.7%) were combined with chordoid features. There was a wide range of MIB-1 labeling indices (4.4–33.5%, mean 15.8%), which were higher in recurrent tumors, tumors with chordoid features, and tumors with necrosis. There was no correlation between MIB-1 labeling indices and brain invasion. The study illustrates aggressive behavior of clear cell meningioma and frequently combined chordoid features in our cases.
Literature
1.
go back to reference Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. World Health Organization classification of tumors. IARC Press, Lyon, pp 176–184 Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. World Health Organization classification of tumors. IARC Press, Lyon, pp 176–184
2.
go back to reference Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon, pp 164–172 Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon, pp 164–172
3.
go back to reference Scheithauer BW (1990) Tumors of the meninges: proposed modification of the World Health Organization classification. Acta Neuropathol 80:343–354PubMedCrossRef Scheithauer BW (1990) Tumors of the meninges: proposed modification of the World Health Organization classification. Acta Neuropathol 80:343–354PubMedCrossRef
4.
go back to reference Harkin JC, Leonard GL (1988) Abnormal amianthoid fibers in meningioma. Acta Neuropathol 76:638–639PubMedCrossRef Harkin JC, Leonard GL (1988) Abnormal amianthoid fibers in meningioma. Acta Neuropathol 76:638–639PubMedCrossRef
5.
go back to reference Manivel JC, Sung JH (1990) Pathology of meningiomas. Pathol Annu 25(Pt 2):159–192PubMed Manivel JC, Sung JH (1990) Pathology of meningiomas. Pathol Annu 25(Pt 2):159–192PubMed
6.
go back to reference Shiraishi K (1991) Glycogen-rich meningioma: case report and short review. Neurosurg Rev 14:61–64PubMed Shiraishi K (1991) Glycogen-rich meningioma: case report and short review. Neurosurg Rev 14:61–64PubMed
7.
go back to reference Kleihues P, Burger PC, Scheithauer BW (1993) Tumors of the meninges. In: Sobin LH (ed) Histological typing of tumors of the central nervous system, 2nd edn. Springer-Verlag, Berlin, pp 33–42 Kleihues P, Burger PC, Scheithauer BW (1993) Tumors of the meninges. In: Sobin LH (ed) Histological typing of tumors of the central nervous system, 2nd edn. Springer-Verlag, Berlin, pp 33–42
8.
go back to reference Zorludemir S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer FB (1995) Clear cell meningioma: a clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol 19:493–505PubMedCrossRef Zorludemir S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer FB (1995) Clear cell meningioma: a clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol 19:493–505PubMedCrossRef
9.
go back to reference Alameda F, Lloreta J, Ferrer MD, Corominas JM, Galitó E, Serrano S (1999) Clear cell meningioma of the lumbo-sacral spine with chordoid features. Ultrastruct Pathol 23:51–58PubMedCrossRef Alameda F, Lloreta J, Ferrer MD, Corominas JM, Galitó E, Serrano S (1999) Clear cell meningioma of the lumbo-sacral spine with chordoid features. Ultrastruct Pathol 23:51–58PubMedCrossRef
10.
go back to reference Payano M, Kondo Y, Kashima K, Daa T, Yatsuka T, Kida H, Nakayama I, Yokoyama S (2004) Two cases of nondura-based clear cell meningioma of the cauda equina. APMIS 112:141–147PubMedCrossRef Payano M, Kondo Y, Kashima K, Daa T, Yatsuka T, Kida H, Nakayama I, Yokoyama S (2004) Two cases of nondura-based clear cell meningioma of the cauda equina. APMIS 112:141–147PubMedCrossRef
11.
go back to reference Vural M, Arslantaş A, Ciftçi E, Artan S, Atasoy MA (2007) An unusual case of cervical clear-cell meningioma in pediatric age. Child’s Nerv Syst 23:225–229CrossRef Vural M, Arslantaş A, Ciftçi E, Artan S, Atasoy MA (2007) An unusual case of cervical clear-cell meningioma in pediatric age. Child’s Nerv Syst 23:225–229CrossRef
12.
go back to reference Tena-Suck ML, Salinas-Lara C, Gómez C, Bojórquez DR (2007) Frontotemporal clear cell meningioma. Report of 3 cases. Annals of Diagnostic Pathol 11:182–189CrossRef Tena-Suck ML, Salinas-Lara C, Gómez C, Bojórquez DR (2007) Frontotemporal clear cell meningioma. Report of 3 cases. Annals of Diagnostic Pathol 11:182–189CrossRef
13.
go back to reference Tong-Tong W, Li-Juan B, Zhi L, Yang L, Bo-Ning L, Quan H (2010) Clear cell meningioma with anaplastic features: case report and review of literature. Pathol Res Pract 206:349–354PubMedCrossRef Tong-Tong W, Li-Juan B, Zhi L, Yang L, Bo-Ning L, Quan H (2010) Clear cell meningioma with anaplastic features: case report and review of literature. Pathol Res Pract 206:349–354PubMedCrossRef
14.
go back to reference Ma L, Liu WK, Wang K, Shrestha B, Zhang YK (2009) Intracranial clear-cell meningioma. Acta Neurochir 151:373–378 discussion 378CrossRef Ma L, Liu WK, Wang K, Shrestha B, Zhang YK (2009) Intracranial clear-cell meningioma. Acta Neurochir 151:373–378 discussion 378CrossRef
15.
go back to reference Jain D, Sharma MC, Sarkar C, Suri V, Garg A, Singh M, Sharma BS, Mahapatra AK (2007) Clear cell meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases. J Neurooncol 81:315–321PubMedCrossRef Jain D, Sharma MC, Sarkar C, Suri V, Garg A, Singh M, Sharma BS, Mahapatra AK (2007) Clear cell meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases. J Neurooncol 81:315–321PubMedCrossRef
16.
go back to reference Rousselot C, Francois P, Jan M, Bergemer AM (2010) Report of seven cases of clear cell meningioma and a literature review. Ann Pathol 30:73–82PubMedCrossRef Rousselot C, Francois P, Jan M, Bergemer AM (2010) Report of seven cases of clear cell meningioma and a literature review. Ann Pathol 30:73–82PubMedCrossRef
17.
go back to reference Prayson RA, Chamberlain WA, Angelov L (2010) Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma. Appl Immunohistochem Mol Morphol. doi:10.1097/PAI.0b013e3181dd35d2 Prayson RA, Chamberlain WA, Angelov L (2010) Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma. Appl Immunohistochem Mol Morphol. doi:10.​1097/​PAI.​0b013e3181dd35d2​
18.
go back to reference Bailey D, Baumal R, Law J, Sheldon K, Kannampuzha P, Stratis M, Kahn H, Marks A (1986) Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA 83:5291–5295PubMedCrossRef Bailey D, Baumal R, Law J, Sheldon K, Kannampuzha P, Stratis M, Kahn H, Marks A (1986) Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA 83:5291–5295PubMedCrossRef
19.
go back to reference Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D (1997) Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151:1141–1152PubMed Breiteneder-Geleff S, Matsui K, Soleiman A, Meraner P, Poczewski H, Kalt R, Schaffner G, Kerjaschki D (1997) Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. Am J Pathol 151:1141–1152PubMed
20.
go back to reference Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166:913–921PubMedCrossRef Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M (2005) Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol 166:913–921PubMedCrossRef
21.
go back to reference Evangelou E, Kyzas PA, Trikalinos TA (2005) Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol 18:1490–1497PubMedCrossRef Evangelou E, Kyzas PA, Trikalinos TA (2005) Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach. Mod Pathol 18:1490–1497PubMedCrossRef
22.
go back to reference Ordóñez NG (2006) Podoplanin: a novel diagnostic immunohistochemical marker. Adv Anat Pathol 13:83–88PubMedCrossRef Ordóñez NG (2006) Podoplanin: a novel diagnostic immunohistochemical marker. Adv Anat Pathol 13:83–88PubMedCrossRef
23.
go back to reference Roy S, Chu A, Trojanowski JQ, Zhang PJ (2005) D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol 109:497–502PubMedCrossRef Roy S, Chu A, Trojanowski JQ, Zhang PJ (2005) D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol 109:497–502PubMedCrossRef
24.
go back to reference Shibahara J, Kashima T, Kikuchi Y, Kunita A, Fukayama M (2006) Podoplanin is expressed in subsets of tumors of the central nervous system. Virchows Arch 448:493–499PubMedCrossRef Shibahara J, Kashima T, Kikuchi Y, Kunita A, Fukayama M (2006) Podoplanin is expressed in subsets of tumors of the central nervous system. Virchows Arch 448:493–499PubMedCrossRef
25.
go back to reference Huse JT, Pasha TL, Zhang PJ (2007) D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma. Acta Neuropathol 113:87–94PubMedCrossRef Huse JT, Pasha TL, Zhang PJ (2007) D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma. Acta Neuropathol 113:87–94PubMedCrossRef
27.
Metadata
Title
Clear cell meningioma with frequent chordoid features and aggressive behavior: a clinicopathologic study of ten cases at a single institution
Authors
Han-Ku Chen
You-Ting Wu
Yu-Jun Lin
Jui-Wei Lin
Publication date
01-07-2011
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2011
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-010-0418-z

Other articles of this Issue 3/2011

Journal of Neuro-Oncology 3/2011 Go to the issue